These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38308262)

  • 1. Understanding the barriers and facilitators to implementing and sustaining Mobile Overdose Response Services from the perspective of Canadian key interest groups: a qualitative study.
    Seo B; Rider N; Rioux W; Teare A; Jones S; Taplay P; Monty Ghosh S
    Harm Reduct J; 2024 Feb; 21(1):28. PubMed ID: 38308262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of Canadian Healthcare and Harm Reduction Workers on Mobile Overdose Response Services: A Qualitative Study.
    Sedaghat N; Seo B; Rider N; Rioux W; Ghosh SM
    Subst Use Addctn J; 2024 Jul; 45(3):506-514. PubMed ID: 38525593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beliefs, attitudes and experiences of virtual overdose monitoring services from the perspectives of people who use substances in Canada: a qualitative study.
    Marshall T; Viste D; Jones S; Kim J; Lee A; Jafri F; Krieg O; Ghosh SM
    Harm Reduct J; 2023 Jun; 20(1):80. PubMed ID: 37355610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preference for hotline versus mobile application/countdown-based mobile overdose response services: a qualitative study.
    Rioux W; Teare A; Rider N; Jones S; Ghosh SM
    Harm Reduct J; 2024 Feb; 21(1):31. PubMed ID: 38317194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.
    Mansoor M; Foreman-Mackey A; Ivsins A; Bardwell G
    Harm Reduct J; 2023 Apr; 20(1):61. PubMed ID: 37118799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual overdose monitoring services/mobile overdose response services: estimated number of potentially averted drug poisoning fatality events by various telephone and digital-based overdose prevention/harm reduction services in North America.
    Rioux W; Enns B; Ghosh SM
    Front Public Health; 2023; 11():1242795. PubMed ID: 37927877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating uses of peer-operated Virtual Overdose Monitoring Services (VOMS) beyond overdose response: a qualitative study.
    Rider N; Safi F; Marshall T; Jones S; Seo B; Viste D; Taplay PE; Rioux W; Ghosh SM
    Am J Drug Alcohol Abuse; 2023 Nov; 49(6):809-817. PubMed ID: 37956211
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study.
    Safi F; Rioux W; Rider N; Fornssler B; Jones S; Ghosh SM
    Harm Reduct J; 2023 May; 20(1):64. PubMed ID: 37158926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.
    Moran L; Ondocsin J; Outram S; Ciccarone D; Werb D; Holm N; Arnold EA
    Harm Reduct J; 2024 May; 21(1):92. PubMed ID: 38734643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs.
    Ondocsin J; Ciccarone D; Moran L; Outram S; Werb D; Thomas L; Arnold EA
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to, and Facilitators of, Checking Drugs for Adulterants in the Era of Fentanyl and Xylazine: Qualitative Study.
    Aronson ID; Ardouin-Guerrier MA; Baus JE; Bennett AS
    JMIR Form Res; 2024 Jul; 8():e56755. PubMed ID: 38959505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study.
    Ivsins A; Boyd J; Mayer S; Collins A; Sutherland C; Kerr T; McNeil R
    Drug Alcohol Depend; 2020 Nov; 216():108202. PubMed ID: 32948372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Everybody is impacted. Everybody's hurting": Grief, loss and the emotional impacts of overdose on harm reduction workers.
    Kolla G; Khorasheh T; Dodd Z; Greig S; Altenberg J; Perreault Y; Bayoumi AM; Kenny KS
    Int J Drug Policy; 2024 May; 127():104419. PubMed ID: 38599035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C; Matsumoto A; Boulad M; Stopka TJ
    Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.